Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)
Clinical trial NCT07290257 · RECRUITING
Trial details
- NCT number
- NCT07290257
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-25
- Primary completion
- 2030-09-22
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.